LECAP Asset Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,605
Closed -$805K 320
2026
Q1
$805K Buy
15,605
+4,595
+42% +$322K 0.3% 142
2025
Q4
$1.02M Buy
+11,010
New +$1.05M 0.4% 94
2025
Q1
Sell
-5,254
Closed -$974K 341
2024
Q4
$974K Sell
5,254
-1,412
-21% -$274K 0.26% 154
2024
Q3
$1.41M Sell
6,666
-4,531
-40% -$787K 0.3% 131
2024
Q2
$1.5M Buy
+11,197
New +$2.12M 0.32% 122

Other funds holding INSP

LECAP Asset Management's INSP Position: Q2 2026 in Review

LECAP Asset Management sold out of Inspire Medical Systems (INSP) in Q2 2026, closing a stake of 15,605 shares — an estimated $805K sold.

LECAP Asset Management first reported a position in INSP in Q2 2024 and held it in 5 quarters. The position peaked at $1.5M in Q2 2024. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • LECAP Asset Management reported no remaining Inspire Medical Systems position as of Q2 2026 after selling out during the quarter.
  • LECAP Asset Management sold 15,605 Inspire Medical Systems shares in Q2 2026, an estimated $805K.
  • LECAP Asset Management first reported a position in Inspire Medical Systems in Q2 2024 and held it in 5 quarters.
  • LECAP Asset Management's Inspire Medical Systems position peaked at $1.5M in Q2 2024.
  • 276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on LECAP Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.